Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis

References

• Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218–1227.
   PubMed Web of Science ®Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–368.
   PubMed Web of Science ®Google Scholar
• Bollow M, Fischer T, Reisshauer H, et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis. 2000;59:135–140.
   PubMed Web of Science ®Google Scholar
• Lurati AM, laria A, marrazza M, et al. The macrophages in rheumatic diseases. J Inflamm Res. 2016;9:1–11.
   PubMed Web of Science ®Google Scholar
• Baeten D, De Keyser F. The histopathology of spondyloarthropathy. Curr Mol Med. 2004;4:1–12.
   PubMed Web of Science ®Google Scholar
• Claudepierre P, Voisin M-C. The entheses: histology, pathology, and pathophysiology. Joint Bone Spine. 2005;72:32–37.
   PubMed Web of Science ®Google Scholar
• Baeten D, Kruithof E, De Rycke L, et al. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy. Arthritis Res Ther. 2005;7:R359–R369.
   PubMed Web of Science ®Google Scholar
• Pedersen SJ, Poddubnyy D, Sørensen IJ, et al. Course of magnetic resonance imaging-detected inflammation and structural lesions in the sacroiliac joints of patients in the randomized, double-blind, placebo-controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods. Arthritis Rheumatol. 2016;68:418–429.
   PubMed Web of Science ®Google Scholar
• Kiltz U, Baraliakos X, Regel A, et al. Causes of pain in patients with axial spondyloarthritis. Clin Exp Rheumatol. 2017;35 Suppl 107:102–107.
   PubMedGoogle Scholar
• Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73–84.
   PubMed Web of Science ®Google Scholar
• Poddubnyy D, Sieper J. What is the best treatment target in axial spondyloarthritis: tumour necrosis factor α, interleukin 17. Or Both? Rheumatology. 2017;76:1614.
   Google Scholar
• Braun J, Baraliakos X, Deodhar A, et al. Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. Ann Rheum Dis. 2017;76:1070–1077.
   PubMed Web of Science ®Google Scholar
• van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017; 76:978–991.
   PubMed Web of Science ®Google Scholar
• Hededal P, Østergaard M, Sørensen IJ, et al. Development and validation of MRI sacroiliac joint scoring methods for the semiaxial scan plane corresponding to the Berlin and SPARCC MRI scoring methods, and of a New Global MRI Sacroiliac Joint Method. J Rheumatol. 2017;pii:161583.
   Google Scholar
• Rey-Giraud F, Hafner M, Ries CH. In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS ONE. 2012;7:e42656.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677–686.
   PubMed Web of Science ®Google Scholar
• Kristiansen M, Graversen JH, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409:198–201.
   PubMed Web of Science ®Google Scholar
• Møller HJ. Soluble CD163. Scand. J Clin Lab Invest. 2012;72:1–13.
   PubMed Web of Science ®Google Scholar
• Greisen SR, Møller HJ, Stengaard-Pedersen K, et al. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. Clin Exp Rheumatol. 2011;29:689–692.
   PubMed Web of Science ®Google Scholar
• Martinez-Pomares L. The mannose receptor. J Leukoc Biol. 2012;92:1177–1186.
   PubMed Web of Science ®Google Scholar
• Andersen MN, Andersen NF, Rødgaard-Hansen S, et al. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): implications in multiple myeloma. Leuk Res. 2015;39:971–975.
   PubMed Web of Science ®Google Scholar
• Heftdal LD, Stengaard-Pedersen K, Ørnbjerg LM, et al. Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity. Scand J Clin Lab Invest. 2017;33:1–5.
   Google Scholar
• Greisen SR, Møller HJ, Stengaard-Pedersen K, et al. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs. Clin Exp Rheumatol. 2015;33:1–5.
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777–783.
   PubMed Web of Science ®Google Scholar
• Paramarta JE, Baeten D. Spondyloarthritis: from unifying concepts to improved treatment. Rheumatology (Oxford). 2014;53:1547–1559.
   PubMed Web of Science ®Google Scholar
• Østgård RD, Deleuran BW, Dam MY, et al. Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis. Scand J Rheumatol. 2017;22:1–8.
   Google Scholar
• Arnbak B, Grethe Jurik A, Hørslev-Petersen K, et al. Associations between spondyloarthritis features and magnetic resonance imaging findings: a cross-sectional analysis of 1,020 patients with persistent low back pain. Arthritis Rheumatol. 2016;68:892–900.
   PubMed Web of Science ®Google Scholar
• Hermansen LT, Loft AG, Christiansen AA, et al. No diagnostic utility of antibody patterns against Klebsiella pneumoniae capsular serotypes in patients with axial spondyloarthritis vs. patients with non-specific low back pain: a cross-sectional study. Scand J Rheumatol. 2017;46:296–302.
   PubMed Web of Science ®Google Scholar
• Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68:i41–i44.
   Web of Science ®Google Scholar
• Møller HJ, Hald K, Moestrup SK. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J Clin Lab Invest. 2002;62:293–299.
   PubMed Web of Science ®Google Scholar
• Rødgaard-Hansen S, Rafique A, Christensen PA, et al. A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. Clin Chem Lab Med. 2014;52:1–9.
   PubMed Web of Science ®Google Scholar
• Madsen KB, Jurik AG. MRI grading method for active and chronic spinal changes in spondyloarthritis. Clin Radiol. 2010;65:6–14.
   PubMed Web of Science ®Google Scholar
• Arnbak B, Jensen TS, Manniche C, et al. Spondyloarthritis-related and degenerative MRI changes in the axial skeleton–an inter- and intra-observer agreement study. BMC Musculoskelet Disord. 2013;14:274.
   PubMed Web of Science ®Google Scholar
• Madsen KB, Jurik AG. Magnetic resonance imaging grading system for active and chronic spondylarthritis changes in the sacroiliac joint. Arthritis Care Res (Hoboken). 2010;62:11–18.
   PubMed Web of Science ®Google Scholar
• Grønbaek H, Rødgaard-Hansen S, Aagaard NK, et al. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). J Hepatol. 2016;64:813–822.
   PubMed Web of Science ®Google Scholar
• Rødgaard-Hansen S, Rafique A, Weis N, et al. Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival. Infect Dis. 2015;47:203–208.
   PubMed Web of Science ®Google Scholar
• Cope FO, Abbruzzese B, Sanders J, et al. The inextricable axis of targeted diagnostic imaging and therapy: an immunological natural history approach. Nucl Med Biol. 2016;43:215–225.
   PubMed Web of Science ®Google Scholar
• Roca H, Varsos ZS, Sud S, et al. CCL2 and interleukin-6 promote survival of human CD11b + peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem. 2009;284:34342–34354.
   PubMed Web of Science ®Google Scholar
• Baeten D, Demetter P, Cuvelier CA, et al. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol. 2002;196:343–350.
   PubMed Web of Science ®Google Scholar